We Welcome Your Interest
The CBI community includes stakeholders from across the healthcare innovation system. CBI provides its community members with the opportunity to help shape the future of biomedical innovation. We welcome your interest in collaborating with us as we shape our ongoing strategic vision and inter-disciplinary research and educational activities.
In addition to the broad engagement of the MIT and Harvard-MIT Division of Health Science and Technology (HST) research communities, CBI greatly appreciates the support and participation of the following organizations:
Consortium Members and Collaborators (*Consortium Members)
|Alnylam Pharmaceuticals*||Georgetown University||National Institutes of Health (NIH)|
|Amgen*||Health Canada||Natl. Inst. of Standards & Technology (NIST)|
|Baxter*||Health Sci. Authority of Singapore (HSA)||NICE|
|Biogen Idec*||Inno Biologics Sdn. Bhd.*||Novartis Pharma AG*|
|BioMarin*||Johnson & Johnson*||Novartis Vaccines & Diagnostics|
|Boehringer Ingelheim*||KEW Group||Pfizer*|
|Bristol-Myers Squibb*||Life Technologies||Quintiles|
|Brookings Institution||Massachusetts General Hospital||sanofi*|
|Cntrs. for Disease Cont. and Prev. (CDC)||MedImmune*||sanofi pasteur*|
|Dana Farber Cancer Institute||Memorial Sloan-Kettering||Shire*|
|EMD Millipore*||Merial*||University of Prince Edward Island|
|Eur. Medicines Agency (EMA)||Merrimack Pharmaceuticals*||US Food & Drug Association (FDA)|
CBI is also grateful to the following foundations for their financial support:
|Alfred P. Sloan Foundation|
|Massachusetts Technology Collaborative (John Adams Innovation Institute grant)|
|Merck Company Foundation (Program on Pharmaceutical Policy Issues grant)|
For general information on supporting CBI’s goals and mission, please contact us at email@example.com.
For additional information on supporting the NEWDIGS program, please contact Gigi Hirsch at firstname.lastname@example.org.
For additional information on supporting the BioMAN & CAACB programs, please contact Stacy Springs at email@example.com.